NIH and Iowa researchers shed light on molecular mechanisms of inherited form of human deafness
A small-molecule drug is one of the first to preserve hearing in a mouse model of an inherited form of progressive human deafness, report investigators at the University of Iowa, Iowa City, and the National Institutes of Health’s National Institute on Deafness and Other Communication Disorders (NIDCD). The study, which appears online in Cell, sheds light on the molecular mechanism that underlies a form of deafness (DFNA27), and suggests a new treatment strategy.
“We were able to partially restore hearing, especially at lower frequencies, and save some sensory hair cells,” said Thomas B. Friedman, Ph.D., chief of the Laboratory of Human Molecular Genetics at the NIDCD, and a coauthor of the study. “If additional studies show that small-molecule-based drugs are effective in treating DFNA27 deafness in people, it’s possible that using similar approaches might work for other inherited forms of progressive hearing loss.”
The seed for the advance was planted a decade ago, when NIDCD researchers led by Friedman and Robert J. Morell, Ph.D., another coauthor of the current study, analyzed the genomes of members of an extended family, dubbed LMG2. Deafness is genetically dominant in the LMG2 family, meaning that a child needs to inherit only one copy of the defective gene from a parent to have progressive hearing loss.
The investigators localized the deafness-causing mutation to a region on chromosome four called DFNA27, which includes a dozen or so genes. The precise location of the mutation eluded the NIDCD team, however.
A crucial clue to explain the DFNA27 form of progressive deafness arose from later studies of the mouse RE1 Silencing Transcription Factor, or Rest, gene conducted by researchers at the University of Iowa. Botond Banfi, M.D., Ph.D. and Yoko Nakano, Ph.D., lead authors of the current study, discovered that mouse Rest is regulated through an unusual mechanism in the sensory cells of the inner ear, and this regulation is critical for hearing in mice. Because the human counterpart of the mouse Rest gene is located in the DFNA27 region, the Iowa and NIDCD researchers teamed up to reexamine the mystery of DFNA27 progressive deafness.
The coding sequence of a protein is generated from a gene by stitching together segments called exons while editing out the intervening segments. The resulting molecule serves as the template for a specific protein. Most previous studies had missed exon 4 in the Rest gene because this small exon is not edited into the RestmRNA in most cells. The normal function of the REST protein is to shut off genes that need to be active only in a very few cell types.
When Banfi’s team deleted exon 4 of Rest in mice, inner ear hair cells died, and mice became deaf. Many genes that should have been active were shut off in hair cells prior to their death. Working together, Friedman’s and Banfi’s groups pinpointed the deafness mutation in the LMG2 family. They discovered that the mutation lies near exon 4, altering the boundaries of exon 4, and interferes with the inactivation of REST in hair cells.
“We found that incorporating exon 4 into the REST mRNA acts like a switch in sensory hair cells. It turns off REST and allows many genes to be turned on,” said Banfi. “Some of these turned-on genes are important for hair cell survival and hearing.”
The investigators used Banfi’s exon 4-deficient mice as a model for DFNA27 deafness. Since REST suppresses gene expression through a process called histone deacetylation, they wanted to see if blocking this process could reduce hearing loss. Using small-molecule drugs that inhibit this process, the investigators were able to turn off REST and partially restore hearing.
“These results demonstrate the value of studying the molecular mechanisms that underlie inherited forms of deafness,” said Andrew J. Griffith, scientific director of the NIDCD. “By following these genetic leads, we find novel and unexpected pathways that can, in cases such as this one, uncover unexpected potential treatment strategies in humans.”
The Latest on: Hearing restoration
via Google News
The Latest on: Hearing restoration
- Listen up: Hearing tests and care are important parts of healthy agingon October 18, 2019 at 2:08 am
Jordan said that about 1 in 3 people 65 and over has hearing loss. By the time you’ve noticed a hearing loss, Jordan said, you should probably have already had a test. “I encourage people to start ...
- 'Hearing Aids Could Become As Common As Glasses' - More Than 1.1 Billion Young People Face Hearing Losson October 17, 2019 at 10:43 pm
We’ve had access to music and sound on-the-go for the better part of four decades now, and people are experiencing the effects. “Some studies have shown that cases of noise-induced hearing loss has ...
- These discreet earplugs might save your hearing—and they're under $20on October 17, 2019 at 2:30 pm
If you buy something through these links, NBC News and StackCommerce make some revenue from your purchase. More than 20 percent of young people are beginning to experience hearing loss. And many don't ...
- Enjoying music shouldn't mean losing your hearing.on October 17, 2019 at 2:10 pm
More than 20 percent of young people are beginning to experience hearing loss. And many don't even know it. From loud concerts to bustling city streets, there are plenty of decibel-pounding occasions ...
- Soft Auditory Brainstem Hearing Implants from Platinum Kirigamion October 17, 2019 at 9:19 am
People who have hearing loss because of inner ear damage or from a poorly functioning auditory nerve are not helped by cochlear and middle ear implants. Auditory brainstem implants (ABI), which bypass ...
- $7.7 Billion Hearing Aids Markets - Global Forecast to 2023on October 16, 2019 at 5:14 pm
Growth will be driven by the increasing global prevalence of hearing loss. According to the World Health Organization (WHO), approximately 466 million people have disabling hearing loss worldwide, ...
- Houston pediatric hearing loss organization to move to Texas Medical Center next yearon October 16, 2019 at 12:43 pm
The Center for Hearing and Speech, a resource for pediatric hearing loss that includes a school for young children, plans to move into its new location in the Texas Medical Center next fall. After ...
- We used smartphones to screen young children for vision and hearing losson October 14, 2019 at 5:51 am
But more than 90% of children with hearing or vision loss live in low and middle-income countries where services to detect problems early are unavailable. Called invisible disabilities hearing and ...
- Frequency Therapeutics Commences Dosing in its Phase 2a Study of FX-322 for Sensorineural Hearing Loss; FDA Grants FX-322 Fast Track Designationon October 10, 2019 at 5:05 pm
FX-322 is being developed for the treatment of sensorineural hearing loss (SNHL), the most common type of hearing loss. The company also announced today that the U.S. Food and Drug Administration (FDA ...
via Bing News